[Early results of the use of 2-p-chlorophenyl-3-methyl-2,3-butanediol (phenaglycodol) in neuropsychiatric therapy].
D002072:Butylene Glycols; D006801:Humans; D001523:Mental Disorders / Q000628:therapy*; D014149:Tranquilizing Agents / Q000628:therapy*
D002072:Butylene Glycols; D014149:Tranquilizing Agents; C026978:2,3-butylene glycol; C027886:phenaglycodol
MENTAL DISORDERS/therapy; TRANQUILIZING AGENTS/therapy